Latka logo
Orna Therapeutics logo

Orna Therapeuticsrevenue, valuation & funding

Watertown, MassachusettsFounded 2019CEO Joseph Bolen

Orna Therapeutics is a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases.

ornatx.comLinkedInUpdated Nov 29, 2025
Annual revenue
$41.2M
Dec 2024
Valuation
$1.5B
Aug 2022
Total raised
$301M
2 rounds
Employees
176
Nov 2025

Orna Therapeutics revenue

Orna Therapeutics' annual revenue was $41.2M in December 2024 (source not recorded), the most recent figure on record.

$0
$20M
$40M
$0
–
$41.2M
20192020–232024
ReportedFounded 2019 at $0; every reading has its own bar
As ofRevenueSource
Dec 2024$41.2M–

– source not recorded

Orna Therapeutics valuation

Orna Therapeutics is privately held, so there is no Orna Therapeutics stock to buy. Investors valued it at $1.5B in its August 2022 Series B.

Orna Therapeutics funding rounds & investors

Orna Therapeutics has raised $301M across two rounds since 2021. The latest was a $221M Series B in August 2022.

DateRoundRaisedValuation
Aug 2022Series B$221M$1.5B
Feb 2021Series A$80M–
Total raised$301M

Orna Therapeutics CEO, founders & employees

Joseph Bolen founded Orna Therapeutics in 2019 and runs it as CEO. Orna Therapeutics has 176 employees (November 2025).

0
50
100
150
176
2025
ReportedOne figure per year; a reported figure wins over an estimate

Orna Therapeutics FAQ

What is Orna Therapeutics' revenue?

Orna Therapeutics' annual revenue was $41.2M in December 2024 (source not recorded). No later figure is on record.

What is Orna Therapeutics' valuation?

Investors valued Orna Therapeutics at $1.5B in its August 2022 Series B.

How much funding has Orna Therapeutics raised?

Orna Therapeutics has raised $301M across two funding rounds. The latest was a $221M Series B in August 2022.

Is Orna Therapeutics publicly traded?

No. Orna Therapeutics is a private company, so its shares aren't traded on a stock exchange.

How many employees does Orna Therapeutics have?

Orna Therapeutics has 176 employees as of November 2025.

Who is the CEO of Orna Therapeutics?

Joseph Bolen is the CEO of Orna Therapeutics and founded the company in 2019.

Who founded Orna Therapeutics?

Joseph Bolen founded Orna Therapeutics in 2019.

How this page is sourced

Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Nov 29, 2025Data disclaimerReport a correctionClaim this profileRun Orna Therapeutics? Join the podcast